MedPath

Estra-50

Estra-50 & Estra-25

Approved
Approval ID

596a20bd-d93d-4c48-e053-2991aa0ad4ca

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 13, 2024

Manufacturers
FDA

Advanced Pharmaceutical Technology, Inc.

DUNS: 023237884

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

estradiol pellet

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57377-025
Product Classification
G
Generic Name
estradiol pellet
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateJanuary 13, 2024
FDA Product Classification

INGREDIENTS (3)

STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
ESTRADIOLActive
Quantity: 25 mg in 1 1
Code: 4TI98Z838E
Classification: ACTIB

Estradiol pellet

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57377-050
Product Classification
G
Generic Name
Estradiol pellet
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateJanuary 13, 2024
FDA Product Classification

INGREDIENTS (3)

ESTRADIOLActive
Quantity: 50 mg in 1 1
Code: 4TI98Z838E
Classification: ACTIB
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Estra-50 - FDA Drug Approval Details